Rafael F Duarte


Ontology type: schema:Person     


Person Info

NAME

Rafael F

SURNAME

Duarte

Publications in SciGraph latest 50 shown

  • 2019-02-27 Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT in BONE MARROW TRANSPLANTATION
  • 2019 HSCT in Elderly Patients in THE EBMT HANDBOOK
  • 2018-12-07 Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT in BONE MARROW TRANSPLANTATION
  • 2018-10-25 Clinical and morphological practices in the diagnosis of transplant-associated microangiopathy: a study on behalf of Transplant Complications Working Party of the EBMT in BONE MARROW TRANSPLANTATION
  • 2018-09 Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report in BONE MARROW TRANSPLANTATION
  • 2018-08 Variability of nutritional practices in peritransplant period after allogeneic hematopoietic stem cell transplantation: a survey by the Complications and Quality of Life Working Party of the EBMT in BONE MARROW TRANSPLANTATION
  • 2018-07-26 European experience and risk factor analysis of donor cell-derived leukaemias/MDS following haematopoietic cell transplantation in LEUKEMIA
  • 2018-06-13 Use of defibrotide to treat adult patients with transplant-associated thrombotic microangiopathy in BONE MARROW TRANSPLANTATION
  • 2018-06-05 EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment in BONE MARROW TRANSPLANTATION
  • 2018-06 Analysis of the Spanish CCR5-∆32 inventory of cord blood units: lower cell counts in homozygous donors in BONE MARROW TRANSPLANTATION
  • 2018-05-02 Recommendations from the European Society for Blood and Marrow Transplantation (EBMT) for a curriculum in hematopoietic cell transplantation in BONE MARROW TRANSPLANTATION
  • 2018-05 Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT in BONE MARROW TRANSPLANTATION
  • 2018-04 Accuracy and usability of the eGVHD app in assessing the severity of graft-versus-host disease at the 2017 EBMT annual congress in BONE MARROW TRANSPLANTATION
  • 2018-04 Chronic graft-versus-host disease features in double unit cord blood transplantation according to National Institutes of Health 2005 cGVHD Consensus criteria in BONE MARROW TRANSPLANTATION
  • 2018-03 Health-care professionals’ perspective on discussing sexual issues in adult patients after haematopoietic cell transplantation in BONE MARROW TRANSPLANTATION
  • 2018 Supportive Care in ESTABLISHING A HEMATOPOIETIC STEM CELL TRANSPLANTATION UNIT
  • 2017-12 CAR-T cells: the narrow path between hope and bankruptcy? in BONE MARROW TRANSPLANTATION
  • 2017-11 Mesenchymal stromal cells for steroid-refractory acute GvHD in BONE MARROW TRANSPLANTATION
  • 2017-10 JACIE accreditation for blood and marrow transplantation: past, present and future directions of an international model for healthcare quality improvement in BONE MARROW TRANSPLANTATION
  • 2017-08 Haplo-Cord transplantation compared to haploidentical transplantation with post-transplant cyclophosphamide in patients with AML in BONE MARROW TRANSPLANTATION
  • 2017-08 Alloreactivity: the Janus-face of hematopoietic stem cell transplantation in LEUKEMIA
  • 2017-06 Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report in BONE MARROW TRANSPLANTATION
  • 2017-03 The EBMT–ELN working group recommendations on the prophylaxis and treatment of GvHD: a change-control analysis in BONE MARROW TRANSPLANTATION
  • 2017-02 Impact of drug development on the use of stem cell transplantation: a report by the European Society for Blood and Marrow Transplantation (EBMT) in BONE MARROW TRANSPLANTATION
  • 2017-02 Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT in BONE MARROW TRANSPLANTATION
  • 2017-02 Serum galactomannan surveillance may be safely withdrawn from antifungal management of hematology patients on effective antimold prophylaxis: a pilot single-center study in BONE MARROW TRANSPLANTATION
  • 2016-10 The addition of ofatumumab to the conditioning regimen does not improve the outcome of patients with high-risk CLL undergoing reduced intensity allogeneic haematopoietic cell transplantation: a pilot trial from the GETH and GELLC (CLL4 trial) in BONE MARROW TRANSPLANTATION
  • 2016-08 Development, preliminary usability and accuracy testing of the EBMT ‘eGVHD App’ to support GvHD assessment according to NIH criteria—a proof of concept in BONE MARROW TRANSPLANTATION
  • 2016-07 Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation in BONE MARROW TRANSPLANTATION
  • 2016-06 Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually in BONE MARROW TRANSPLANTATION
  • 2015-12 Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMT in BONE MARROW TRANSPLANTATION
  • 2015-08 Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015 in BONE MARROW TRANSPLANTATION
  • 2015-04 Paediatric reduced intensity conditioning: analysis of centre strategies on regimens and definitions by the EBMT Paediatric Diseases and Complications and Quality of Life WP in BONE MARROW TRANSPLANTATION
  • 2015-04 Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants in BONE MARROW TRANSPLANTATION
  • 2015-02 Fungal and viral infections after allogeneic hematopoietic transplantation from unrelated donors in adults: improving outcomes over time in BONE MARROW TRANSPLANTATION
  • 2015-01 Plerixafor in patients with lymphoma and multiple myeloma: effectiveness in cases with very low circulating CD34+ cell levels and preemptive intervention vs remobilization in BONE MARROW TRANSPLANTATION
  • 2014-06 Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation in BONE MARROW TRANSPLANTATION
  • 2014-06 Etiology, clinical features and outcomes of pre-engraftment and post-engraftment bloodstream infection in hematopoietic SCT recipients in BONE MARROW TRANSPLANTATION
  • 2014-04 MicroRNA expression at diagnosis adds relevant prognostic information to molecular categorization in patients with intermediate-risk cytogenetic acute myeloid leukemia in LEUKEMIA
  • 2014-03 Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation in BONE MARROW TRANSPLANTATION
  • 2014-02 Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice in BONE MARROW TRANSPLANTATION
  • 2014-02 Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice in BONE MARROW TRANSPLANTATION
  • 2014-01 Uptake and use of recommendations for the diagnosis, severity scoring and management of chronic GVHD: an international survey of the EBMT–NCI Chronic GVHD Task Force in BONE MARROW TRANSPLANTATION
  • 2014-01 Early engraftment and full-donor chimerism after single-cord blood plus third-party donor dual transplantation in patients with high-risk acute leukemia in BONE MARROW TRANSPLANTATION
  • 2013-11 Bone marrow WT1 levels at diagnosis, post-induction and post-intensification in adult de novo AML in LEUKEMIA
  • 2013-09 Hematopoietic SCT in Europe: data and trends in 2011 in BONE MARROW TRANSPLANTATION
  • 2012-10 Reply to SB Mossad in BONE MARROW TRANSPLANTATION
  • 2012-08 European data on stem cell mobilization with plerixafor in non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma patients. A subgroup analysis of the European Consortium of stem cell mobilization in BONE MARROW TRANSPLANTATION
  • 2012-07 Higher BMI is not a barrier to stem cell mobilization with standard doses of plerixafor and G-CSF in BONE MARROW TRANSPLANTATION
  • 2012-02 Thyroid dysfunction in adult patients late after autologous and allogeneic blood and marrow transplantation in BONE MARROW TRANSPLANTATION
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.73221.35", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.46699.34", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.7445.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.277151.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.414660.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5841.8", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.426108.9", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.414818.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.459389.a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411251.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.410569.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411129.e", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.417656.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.7548.e", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.6530.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.413396.a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.418701.b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.7080.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411730.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.426412.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.476394.b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.418284.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.83440.3b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411327.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.48769.34", 
            "type": "Organization"
          }
        ], 
        "familyName": "Duarte", 
        "givenName": "Rafael F", 
        "id": "sg:person.01321024667.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01321024667.53"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:45", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_496.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01321024667.53'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01321024667.53'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01321024667.53'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01321024667.53'


     

    This table displays all metadata directly associated to this object as RDF triples.

    64 TRIPLES      10 PREDICATES      35 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.01321024667.53 schema:affiliation N4e4948bcf2e54fcf951347865edd000a
    2 https://www.grid.ac/institutes/grid.277151.7
    3 https://www.grid.ac/institutes/grid.410569.f
    4 https://www.grid.ac/institutes/grid.411129.e
    5 https://www.grid.ac/institutes/grid.411251.2
    6 https://www.grid.ac/institutes/grid.411327.2
    7 https://www.grid.ac/institutes/grid.411730.0
    8 https://www.grid.ac/institutes/grid.413396.a
    9 https://www.grid.ac/institutes/grid.414660.1
    10 https://www.grid.ac/institutes/grid.414818.0
    11 https://www.grid.ac/institutes/grid.417656.7
    12 https://www.grid.ac/institutes/grid.418284.3
    13 https://www.grid.ac/institutes/grid.418701.b
    14 https://www.grid.ac/institutes/grid.426108.9
    15 https://www.grid.ac/institutes/grid.426412.7
    16 https://www.grid.ac/institutes/grid.459389.a
    17 https://www.grid.ac/institutes/grid.46699.34
    18 https://www.grid.ac/institutes/grid.476394.b
    19 https://www.grid.ac/institutes/grid.48769.34
    20 https://www.grid.ac/institutes/grid.5841.8
    21 https://www.grid.ac/institutes/grid.6530.0
    22 https://www.grid.ac/institutes/grid.7080.f
    23 https://www.grid.ac/institutes/grid.7445.2
    24 https://www.grid.ac/institutes/grid.7548.e
    25 https://www.grid.ac/institutes/grid.83440.3b
    26 schema:familyName Duarte
    27 schema:givenName Rafael F
    28 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01321024667.53
    29 schema:sdDatePublished 2019-03-07T14:45
    30 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    31 schema:sdPublisher Nbfbdfce2990849d2833fa82acbf46637
    32 sgo:license sg:explorer/license/
    33 sgo:sdDataset persons
    34 rdf:type schema:Person
    35 N4e4948bcf2e54fcf951347865edd000a schema:affiliation https://www.grid.ac/institutes/grid.73221.35
    36 sgo:isCurrent true
    37 rdf:type schema:OrganizationRole
    38 Nbfbdfce2990849d2833fa82acbf46637 schema:name Springer Nature - SN SciGraph project
    39 rdf:type schema:Organization
    40 https://www.grid.ac/institutes/grid.277151.7 schema:Organization
    41 https://www.grid.ac/institutes/grid.410569.f schema:Organization
    42 https://www.grid.ac/institutes/grid.411129.e schema:Organization
    43 https://www.grid.ac/institutes/grid.411251.2 schema:Organization
    44 https://www.grid.ac/institutes/grid.411327.2 schema:Organization
    45 https://www.grid.ac/institutes/grid.411730.0 schema:Organization
    46 https://www.grid.ac/institutes/grid.413396.a schema:Organization
    47 https://www.grid.ac/institutes/grid.414660.1 schema:Organization
    48 https://www.grid.ac/institutes/grid.414818.0 schema:Organization
    49 https://www.grid.ac/institutes/grid.417656.7 schema:Organization
    50 https://www.grid.ac/institutes/grid.418284.3 schema:Organization
    51 https://www.grid.ac/institutes/grid.418701.b schema:Organization
    52 https://www.grid.ac/institutes/grid.426108.9 schema:Organization
    53 https://www.grid.ac/institutes/grid.426412.7 schema:Organization
    54 https://www.grid.ac/institutes/grid.459389.a schema:Organization
    55 https://www.grid.ac/institutes/grid.46699.34 schema:Organization
    56 https://www.grid.ac/institutes/grid.476394.b schema:Organization
    57 https://www.grid.ac/institutes/grid.48769.34 schema:Organization
    58 https://www.grid.ac/institutes/grid.5841.8 schema:Organization
    59 https://www.grid.ac/institutes/grid.6530.0 schema:Organization
    60 https://www.grid.ac/institutes/grid.7080.f schema:Organization
    61 https://www.grid.ac/institutes/grid.73221.35 schema:Organization
    62 https://www.grid.ac/institutes/grid.7445.2 schema:Organization
    63 https://www.grid.ac/institutes/grid.7548.e schema:Organization
    64 https://www.grid.ac/institutes/grid.83440.3b schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...